FDA gives Roche immunotherapy drug priority review

The FDA has awarded Roche an accelerated review of its immunotherapy drug, Tecentriq, to treat non small-cell lung cancer.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news